These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29411649)

  • 1. Alteration in microRNA-155 level correspond to severity of coronary heart disease.
    Qiu XK; Ma J
    Scand J Clin Lab Invest; 2018 May; 78(3):219-223. PubMed ID: 29411649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between elevated plasma microRNA-223 content and severity of coronary heart disease.
    Guo JF; Zhang Y; Zheng QX; Zhang Y; Zhou HH; Cui LM
    Scand J Clin Lab Invest; 2018 Sep; 78(5):373-378. PubMed ID: 29888618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between circulating microRNA-208a and severity of coronary heart disease.
    Zhang Y; Li HH; Yang R; Yang BJ; Gao ZY
    Scand J Clin Lab Invest; 2017 Sep; 77(5):379-384. PubMed ID: 28554251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between microRNA expression and classical risk factors in the risk of coronary heart disease.
    Ding XQ; Ge PC; Liu Z; Jia H; Chen X; An FH; Li LH; Chen ZH; Mao HW; Li ZY; Gu Y; Zhu TB; Li CJ; Wang LS; Ma WZ; Yang ZJ; Jia EZ
    Sci Rep; 2015 Oct; 5():14925. PubMed ID: 26446730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased alpha-defensin expression is associated with risk of coronary heart disease: a feasible predictive inflammatory biomarker of coronary heart disease in hyperlipidemia patients.
    Maneerat Y; Prasongsukarn K; Benjathummarak S; Dechkhajorn W; Chaisri U
    Lipids Health Dis; 2016 Jul; 15():117. PubMed ID: 27430968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miRNA-33: a potential biomarker in patients with coronary artery disease.
    Reddy LL; Shah SAV; Ponde CK; Rajani RM; Ashavaid TF
    Biomarkers; 2019 Feb; 24(1):36-42. PubMed ID: 30022694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNA-33b levels are associated with the presence and severity of coronary heart disease.
    Chen C; Liu Q; Li Y; Yu JW; Wang SD; Xu JL; Liu L
    Scand J Clin Lab Invest; 2024 Apr; 84(2):133-137. PubMed ID: 38597780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating MiR-146a May be a Potential Biomarker of Coronary Heart Disease in Patients with Subclinical Hypothyroidism.
    Quan X; Ji Y; Zhang C; Guo X; Zhang Y; Jia S; Ma W; Fan Y; Wang C
    Cell Physiol Biochem; 2018; 45(1):226-236. PubMed ID: 29357324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LDL-cholesterol to HDL-cholesterol ratio and the severity of coronary and aortic atherosclerosis.
    Momiyama Y; Ohmori R; Fayad ZA; Tanaka N; Kato R; Taniguchi H; Nagata M; Ohsuzu F
    Atherosclerosis; 2012 Jun; 222(2):577-80. PubMed ID: 22516791
    [No Abstract]   [Full Text] [Related]  

  • 10. The apoB100/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography.
    Song Y; Yang Y; Zhang J; Wang Y; He W; Zhang X; Zhu J; Lu Z
    Lipids Health Dis; 2015 Nov; 14():150. PubMed ID: 26582246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-155 is inversely associated with severity of coronary stenotic lesions calculated by the Gensini score.
    Zhu GF; Yang LX; Guo RW; Liu H; Shi YK; Ye JS; Yang ZH
    Coron Artery Dis; 2014 Jun; 25(4):304-10. PubMed ID: 24525789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNA-378 levels serve as a novel biomarker for assessing the severity of coronary stenosis in patients with coronary artery disease.
    Li H; Gao F; Wang X; Wu J; Lu K; Liu M; Li R; Ding L; Wang R
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064817
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease.
    Gao W; He HW; Wang ZM; Zhao H; Lian XQ; Wang YS; Zhu J; Yan JJ; Zhang DG; Yang ZJ; Wang LS
    Lipids Health Dis; 2012 May; 11():55. PubMed ID: 22587332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Effects of Circulating miR-221, miR-130a and miR-155 for Coronary Heart Disease: A Multi-Ethnic Study in China.
    Jia QW; Chen ZH; Ding XQ; Liu JY; Ge PC; An FH; Li LH; Wang LS; Ma WZ; Yang ZJ; Jia EZ
    Cell Physiol Biochem; 2017; 42(2):808-823. PubMed ID: 28628920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Lipoprotein(a)-Containing Circulating Immune Complexes as Markers of Coronary Heart Disease.
    Klesareva EA; Afanas'eva OI; Donskikh VV; Adamova IY; Pokrovskii SN
    Bull Exp Biol Med; 2016 Dec; 162(2):231-236. PubMed ID: 27905032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of circulating lncRNA GAS5 and miR-21 with biochemical indexes, stenosis severity, and inflammatory cytokines in coronary heart disease patients.
    Jiang Y; Du T
    J Clin Lab Anal; 2022 Feb; 36(2):e24202. PubMed ID: 34997773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of circulating microRNA-122 with presence and severity of atherosclerotic lesions.
    Wang YL; Yu W
    PeerJ; 2018; 6():e5218. PubMed ID: 30013851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases.
    Koba S; Hirano T; Ito Y; Tsunoda F; Yokota Y; Ban Y; Iso Y; Suzuki H; Katagiri T
    Atherosclerosis; 2006 Nov; 189(1):206-14. PubMed ID: 16414053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-17-5p as circulating biomarkers for the severity of coronary atherosclerosis in coronary artery disease.
    Chen J; Xu L; Hu Q; Yang S; Zhang B; Jiang H
    Int J Cardiol; 2015 Oct; 197():123-4. PubMed ID: 26134369
    [No Abstract]   [Full Text] [Related]  

  • 20. [The influence of statin therapy on circulating microRNA-92a expression in patients with coronary heart disease].
    Wang H; Lu HM; Yang WH; Luo C; Lu SH; Zhou Y; Lin YZ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):215-8. PubMed ID: 22464573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.